- Home
- CLDI vs FBGL Comparison
CLDI vs FBGL Comparison
Compare CLDI & FBGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- FBGL
- Stock Information
- Founded
- CLDI 2014
- FBGL 1996
- Country
- CLDI United States
- FBGL Singapore
- Employees
- CLDI N/A
- FBGL N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- FBGL Miscellaneous manufacturing industries
- Sector
- CLDI Health Care
- FBGL Consumer Discretionary
- Exchange
- CLDI Nasdaq
- FBGL Nasdaq
- Market Cap
- CLDI 14.0M
- FBGL 12.4M
- IPO Year
- CLDI N/A
- FBGL 2025
- Fundamental
- Price
- CLDI $0.46
- FBGL $0.56
- Analyst Decision
- CLDI Strong Buy
- FBGL
- Analyst Count
- CLDI 2
- FBGL 0
- Target Price
- CLDI $15.00
- FBGL N/A
- AVG Volume (30 Days)
- CLDI 417.3K
- FBGL 1.2M
- Earning Date
- CLDI 05-13-2025
- FBGL 01-01-0001
- Dividend Yield
- CLDI N/A
- FBGL N/A
- EPS Growth
- CLDI N/A
- FBGL N/A
- EPS
- CLDI N/A
- FBGL 0.04
- Revenue
- CLDI N/A
- FBGL $15,607,369.00
- Revenue This Year
- CLDI N/A
- FBGL N/A
- Revenue Next Year
- CLDI N/A
- FBGL N/A
- P/E Ratio
- CLDI N/A
- FBGL $15.10
- Revenue Growth
- CLDI N/A
- FBGL 25.78
- 52 Week Low
- CLDI $0.35
- FBGL $0.60
- 52 Week High
- CLDI $7.40
- FBGL $5.45
- Technical
- Relative Strength Index (RSI)
- CLDI 34.26
- FBGL N/A
- Support Level
- CLDI $0.35
- FBGL N/A
- Resistance Level
- CLDI $0.45
- FBGL N/A
- Average True Range (ATR)
- CLDI 0.08
- FBGL 0.00
- MACD
- CLDI 0.01
- FBGL 0.00
- Stochastic Oscillator
- CLDI 38.97
- FBGL 0.00
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About FBGL FBS Global Limited Ordinary Shares
FBS Global Ltd is a green building contractor and an established interior fit-out specialist in institutional, residential, commercial and industrial building projects. As a green contractor focused on environmentally sound practices, It aims to bid tenders for green building projects, use green construction methods and green materials for construction projects, including design, supply and installation of ceilings, partitions, timber deck, carpet, lead lining, acoustic wall paneling, built-in furniture as well as mechanical and electrical services of a building. The company's revenue is derived mainly from the construction contracts, sales of construction materials, and rendering of services.